NFKB1 and asthma: The sustained activation of NF-κB is considered a powerful pathogenic factor that is involved in acute or chronic inflammatory disorders, including chronic obstructive pulmonary disease (COPD), asthma, multiple sclerosis, atherosclerosis, rheumatoid arthritis, and inflammatory bowel disease (IBD) [38].